Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Prospective, Multicentric, Randomized, Evaluator-blind, Controlled, Interventional Clinical Investigation Evaluating the Clinical Performance and Safety of STYLAGE® HydroMax, a Hyaluronic Acid-based Gel

NCT07153237 is registered in ClinicalTrials.gov with Laboratoires Vivacy as lead sponsor.

NCT NCT07153237
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07153237 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Prospective, Multicentric, Randomized, Evaluator-blind, Controlled, Interventional Clinical Investigation Evaluating the Clinical Performance and Safety of STYLAGE® HydroMax, a Hyaluronic Acid-based Gel
Lead sponsor
Laboratoires Vivacy
Phase
Not applicable
Overall status
Active, not recruiting
Start date
September 9, 2025
Completion date
November 9, 2026
Enrollment
81 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

aesthetic, aging